Padagis, a provider of extended topical and specialty pharmaceuticals, has increased its regional footprint with the acquisition of a facility in Yerucham, Israel, previously operated by Emilia Cosmetics, Ltd.
Padagis President, Pamela Hoffman, confirmed the expansion, stating “The acquisition of the former Emilia Cosmetics, land and facility expands Padagis’ presence in the region. Through this investment, we secure space for future manufacturing and warehousing operations in this important region to support the growing demand for our products.”
The acquisition further bolsters Padagis’ capabilities in the region, adding to its existing operations in Yerucham, Israel. The Yerucham facility specializes in extended topical products, such as nasal sprays and hormone products, serving both the U.S and Israeli markets.
In addition to the Israeli sites, Padagis operates another facility in Minneapolis, Minnesota. The Minneapolis establishment manufactures a diverse range of dosage forms, including controlled substances, primarily for the U.S market. The acquisition is set to reinforce Padagis’ capacity to meet the growing demand for its specialty pharmaceutical products.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.
